PISCIANZ, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 4.328
EU - Europa 3.551
AS - Asia 1.083
SA - Sud America 98
AF - Africa 24
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.096
Nazione #
US - Stati Uniti d'America 4.303
PL - Polonia 2.044
SG - Singapore 405
SE - Svezia 360
IT - Italia 316
CN - Cina 296
HK - Hong Kong 211
UA - Ucraina 158
DE - Germania 131
FR - Francia 107
BR - Brasile 88
RU - Federazione Russa 79
TR - Turchia 74
FI - Finlandia 71
IE - Irlanda 59
BG - Bulgaria 57
NL - Olanda 50
GB - Regno Unito 48
VN - Vietnam 37
BE - Belgio 21
SN - Senegal 18
IN - India 16
CA - Canada 12
AT - Austria 9
DK - Danimarca 8
ES - Italia 8
AU - Australia 6
IR - Iran 5
JP - Giappone 5
CZ - Repubblica Ceca 4
EU - Europa 4
KR - Corea 4
MX - Messico 4
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
ID - Indonesia 3
IL - Israele 3
NO - Norvegia 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
AR - Argentina 2
CR - Costa Rica 2
EC - Ecuador 2
HU - Ungheria 2
LK - Sri Lanka 2
PA - Panama 2
PK - Pakistan 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.096
Città #
Warsaw 2.036
Fairfield 587
Woodbridge 534
Houston 430
Chandler 323
Ann Arbor 309
Ashburn 274
Seattle 260
Wilmington 248
Singapore 226
Hong Kong 211
Jacksonville 166
Cambridge 159
Trieste 112
Princeton 94
Boardman 91
Beijing 62
Columbus 62
Sofia 57
Izmir 56
Dearborn 49
Dublin 45
Moscow 38
Dong Ket 36
Frankfurt am Main 29
Santa Clara 29
Los Angeles 25
San Diego 25
Munich 24
Düsseldorf 23
Brussels 19
Dakar 18
Jinan 18
Hefei 16
Helsinki 16
Nanjing 15
Phoenix 15
New York 14
Rome 14
Falls Church 13
Shannon 13
Dallas 12
Des Moines 11
Kunming 11
Portsmouth 11
Guangzhou 10
Redwood City 10
Shanghai 10
São Paulo 10
Kocaeli 9
Turku 9
Bremen 8
Council Bluffs 8
Hebei 8
Nuremberg 8
Ottawa 8
San Francisco 8
Washington 8
Grafing 7
London 7
Amsterdam 6
Bexley 6
Brooklyn 6
Milan 6
Udine 6
Brescia 5
Catania 5
Chicago 5
Edinburgh 5
Lauterbourg 5
Mumbai 5
Portogruaro 5
Pune 5
Sydney 5
Vienna 5
Boston 4
Brno 4
Fremont 4
Fuzhou 4
Madrid 4
Nanchang 4
Norwalk 4
Roubaix 4
Seoul 4
Shenyang 4
Stockholm 4
Taiyuan 4
Al Mansurah 3
Ankara 3
Aracaju 3
Atlanta 3
Brøndby 3
Detroit 3
Fort Worth 3
Haikou 3
Hangzhou 3
Nürnberg 3
Paris 3
Perugia 3
Sorocaba 3
Totale 7.131
Nome #
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 401
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 369
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 358
Neuronal Dysfunction Associated with Cholesterol Deregulation. 351
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 337
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 330
Type i interferon-mediated autoinflammation due to DNase II deficiency 328
Altered pattern of tumor necrosis factor-Alpha production in peripheral blood monocytes from Crohn's disease basic study 327
Knockdown of MVK does not lead to changes in NALP3 expression or activation 321
Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs 295
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 274
An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers 257
Clinical Genetic Testing of Periodic Fever Syndromes 252
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 236
In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords 216
Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. 212
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 206
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 204
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 203
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 198
Regulatory T-Cell Function Is Impaired in Celiac Disease. 197
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 196
The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation 192
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 184
Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. 178
Selective resistance to different glucocorticoids in severe autoimmune disorders 174
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 169
Putative modifier genes in mevalonate kinase deficiency 166
Impact of methylmercury and other heavy metals exposure on neurocognitive function in children of 7 years old: study protocol of the follow-up 153
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 144
From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders 143
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 136
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 128
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 128
Corrigendum to “Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency” [Immunol. Lett. 214 (2019) 52–54](S0165247819302342)(10.1016/j.imlet.2019.08.003) 125
Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature 123
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic 111
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies 110
null 109
null 108
New Mechanisms in Autoinflammatory Diseases 105
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 91
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies 88
Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations 87
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 83
Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes 75
Priming of the cgas‐sting‐tbk1 pathway enhances lps‐induced release of type i interferons 69
The effect of clodronate on a mevalonate kinase deficiency cellular model. 67
Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency 58
Totale 9.372
Categoria #
all - tutte 23.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 0 0 0 0 0 0 0 0 0 0 0 87
2020/20211.278 125 108 144 126 118 93 108 96 81 154 40 85
2021/2022714 37 30 71 60 48 54 35 27 79 64 43 166
2022/20231.001 114 158 71 133 89 141 6 95 123 16 39 16
2023/2024596 24 46 47 29 55 59 122 106 5 9 43 51
2024/20251.281 22 51 106 136 124 90 96 86 172 171 130 97
Totale 9.372